Merck to help make Johnson & Johnson’s coronavirus vaccine
Joe Biden is to announce deal that will help break shortage of the single-shot vaccine
02 March 2021 - 21:31
New York — US President Joe Biden is expected to announce later on Tuesday that Merck will help manufacture rival Johnson & Johnson's (J&J's) Covid-19 vaccine in a partnership, raising output of the single-shot treatment.
J&J's vaccine production has been slower than promised. Under its contract, the company was supposed to deliver 12-million doses by end-February, but had less than 4-million ready to ship when the vaccine was authorised on Saturday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.